Provided by Tiger Fintech (Singapore) Pte. Ltd.

Vigil Neuroscience, Inc.

7.88
-0.0100-0.13%
Post-market: 7.87-0.0100-0.13%19:56 EDT
Volume:2.11M
Turnover:16.62M
Market Cap:367.77M
PE:-3.84
High:7.89
Open:7.88
Low:7.87
Close:7.89
Loading ...

Vigil Neuroscience Cut to Neutral From Buy by HC Wainwright & Co.

Dow Jones
·
Yesterday

HC Wainwright Downgrades Vigil Neuroscience to Neutral From Buy, Price Target is $8

MT Newswires Live
·
Yesterday

Vigil Neuroscience, Inc. : H.c. Wainwright Cuts Target Price to $8 From $14

THOMSON REUTERS
·
Yesterday

Analysts Offer Insights on Healthcare Companies: Vigil Neuroscience Inc (VIGL), Fisher & Paykel Healthcare Corporation Limited (OtherFSPKF) and Viridian Therapeutics (VRDN)

TIPRANKS
·
26 May

Vigil Neuroscience Inc. Conducted Annual Stockholders Meeting

Reuters
·
24 May

U.S. RESEARCH ROUNDUP-Ralph Lauren, Vigil Neuroscience, Workday

Reuters
·
23 May

Nasdaq Gains Over 50 Points Following Positive Economic Reports: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone

Benzinga
·
23 May

Vigil Neuroscience Inc : Jefferies Cuts to Hold From Buy; Cuts Target Price to $8 From $19

THOMSON REUTERS
·
23 May

Vigil Neuroscience Inc (VIGL) was downgraded to a Hold Rating at Mizuho Securities

TIPRANKS
·
23 May

BUZZ-U.S. STOCKS ON THE MOVE-Hinge Health, Pitney Bowes, Venture Global

Reuters
·
23 May

Sector Update: Health Care Stocks Retreat Thursday Afternoon

MT Newswires Live
·
23 May

Vigil Neuroscience downgraded to Hold from Buy at Jefferies

TIPRANKS
·
23 May

Sanofi to Acquire Vigil Neuroscience in $470 Million Deal to Boost Neurological Pipeline

Reuters
·
22 May

Nasdaq Gains Over 100 Points; BJ's Wholesale Earnings Top Views

Benzinga
·
22 May

Deals of the day-Mergers and acquisitions

Reuters
·
22 May

Vigil Neuroscience Shares up 241% at $7.88 After Sanofi to Buy Co in $470 Mln Deal

THOMSON REUTERS
·
22 May

Sector Update: Health Care Stocks Fall Premarket Thursday.

MT Newswires Live
·
22 May

BUZZ-U.S. STOCKS ON THE MOVE-Analog Devices, Vigil Neuroscience, Ralph Lauren

Reuters
·
22 May

Vigil Neuroscience Cut to Market Perform From Outperform by William Blair

Dow Jones
·
22 May

Vigil Neuroscience Cut to Neutral From Outperform by Wedbush

Dow Jones
·
22 May